Please assess the completion status of the following clinical trial:

Trial Title: Distal Renal Denervation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* systolic BP is equal or greater than 160 mmHg or diastolic BP is equal or greater than 100 mmHg,~* stable (\>3 months) treatment with full doses of at least 3 antihypertensive drugs including a diuretic,~* given written informed consent~Exclusion Criteria:~* secondary hypertension~* 24h-mean systolic BP \<135 mmHg,~* estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m2,~* extended disease of renal artery,~* any other clinically important disorders/comorbidities significantly increasing risk of endovascular intervention (investigator's assessment)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Distal renal denervation (Type: EXPERIMENTAL): Endovascular denervation of segmental branches of renal artery
- Conventional renal denervation (Type: ACTIVE_COMPARATOR): Endovascular denervation of main trunk of renal artery

Based on this trial design, predict the completion outcome and termination type (if applicable).